A Switching Mechanism in Doxorubicin Bioactivation Can Be Exploited to Control Doxorubicin Toxicity

por Finn, Nnenna A., Findley, Harry W., Kemp, Melissa L.
Publicado 2011

The PI-3 kinase-Akt-MDM2-survivin signaling axis in high-risk neuroblastoma: a target for PI-3 kinase inhibitor intervention

por Peirce, Susan K., Findley, Harry W., Prince, Chengyu, Dasgupta, Anindya, Cooper, Todd, Durden, Donald L.
Publicado 2010

PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells

por Crosswell, Hal E, Dasgupta, Anindya, Alvarado, Carlos S, Watt, Tanya, Christensen, James G, De, Pradip, Durden, Donald L, Findley, Harry W
Publicado 2009